{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:16:04Z","timestamp":1791958564732,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcmg.2024.05.013","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:40:45Z","timestamp":1723041645000},"page":"1079-1097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Risk Stratification in Cardiac Sarcoidosis\u00a0With Cardiac Positron Emission Tomography"],"prefix":"10.1016","volume":"17","author":[{"given":"Tahir S.","family":"Kafil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehia","family":"Fanous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Benjamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M.","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulazeez","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Dahrouj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8504-1930","authenticated-orcid":false,"given":"Rami M.","family":"Abazid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Swiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Romsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob S.B.","family":"Beanlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence D.","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Mielniczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tzemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jcmg.2024.05.013_bib1","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jcmg.2024.05.013_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jcmg.2024.05.013_bib3","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jcmg.2024.05.013_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jcmg.2024.05.013_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"2 pt 2","key":"10.1016\/j.jcmg.2024.05.013_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.jcmg.2024.05.013_bib7","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.jcmg.2024.05.013_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2024.05.013_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2017.03.033","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"241","author":"Bravo","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jcmg.2024.05.013_bib10","doi-asserted-by":"crossref","first-page":"81.e9","DOI":"10.1016\/j.crad.2018.09.015","article-title":"Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis","volume":"74","author":"Sgard","year":"2019","journal-title":"Clin Radiol"},{"issue":"7","key":"10.1016\/j.jcmg.2024.05.013_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2 pt 2","key":"10.1016\/j.jcmg.2024.05.013_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jcmg.2017.07.005","article-title":"Maximizing the prognostic value of cardiac PET in patients with suspected cardiac sarcoidosis: a simple semiquantitative score may help","volume":"11","author":"Blankstein","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jcmg.2024.05.013_bib13","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s12350-021-02681-z","article-title":"The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: a systematic review","volume":"28","author":"Ahmed","year":"2021","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"suppl 2","key":"10.1016\/j.jcmg.2024.05.013_bib14","article-title":"Prognostic role of positron emission tomography in patients with known or suspected cardiac sarcoidosis. a systematic review and meta-analysis","volume":"41","author":"Bhatia","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jcmg.2024.05.013_bib15","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.jcmg.2024.05.013_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jcmg.2024.05.013_bib17","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Hiraga","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord"},{"issue":"4","key":"10.1016\/j.jcmg.2024.05.013_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s12350-019-01916-4","article-title":"The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction","volume":"28","author":"Koyanagawa","year":"2021","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"8","key":"10.1016\/j.jcmg.2024.05.013_bib19","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"suppl 2","key":"10.1016\/j.jcmg.2024.05.013_bib20","first-page":"S151","article-title":"Baseline and follow-up 18FDG PET\/CT in the management of ventricular tachycardia due to cardiac sarcoidosis","volume":"41","author":"Nukala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13 suppl","key":"10.1016\/j.jcmg.2024.05.013_bib21","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0735-1097(16)31824-1","article-title":"High risk of malignant ventricular arrhythmias in cardiac sarcoidosis associated with failure to suppress myocardial inflammation assessed by FDG-PET scanning","volume":"67","author":"Pender","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2024.05.013_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjcard.2020.08.007","article-title":"Utility of\u00a0cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"134","author":"Gowani","year":"2020","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jcmg.2024.05.013_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"6","key":"10.1016\/j.jcmg.2024.05.013_bib24","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s12350-018-01582-y","article-title":"Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; a systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"8","key":"10.1016\/j.jcmg.2024.05.013_bib25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.jcmg.2024.05.013_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"issue":"40","key":"10.1016\/j.jcmg.2024.05.013_bib27","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jcmg.2024.05.013_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.acra.2014.01.008","article-title":"The role of 18F-FDG-PET and PET\/CT in patients with sarcoidosis: an updated evidence-based review","volume":"21","author":"Treglia","year":"2014","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1016\/j.jcmg.2024.05.013_bib29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/20009666.2021.1948668","article-title":"Fulminant cardiogenic shock due to cardiac sarcoidosis","volume":"11","author":"Genovese","year":"2021","journal-title":"J\u00a0Community Hosp Intern Med Perspect"},{"issue":"11","key":"10.1016\/j.jcmg.2024.05.013_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy","volume":"13","author":"Ammirati","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcmg.2024.05.013_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am Heart J"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X24002043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X24002043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T03:58:28Z","timestamp":1756699108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X24002043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1936878X24002043"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2024.05.013","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Stratification in Cardiac Sarcoidosis\u00a0With Cardiac Positron Emission Tomography","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2024.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}